Intradermal Botulinum Toxin A Injection Versus Topical 2% Glycopyrrolate for the Treatment of Primary Facial Hyperhidrosis: A Pilot Study and Review of Literature.

Author: KhashabaShrook A, NofalEman, SalemSomaia

Paper Details 
Original Abstract of the Article :
BACKGROUND: Facial hyperhidrosis (HH), a common problem with both cosmetic and psychological impact, interferes with quality of life. Wide range of treatment options is available for HH. Finding the most effective and yet a safe, tolerable option is the main target. OBJECTIVE: To evaluate and compa...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/35917265

データ提供:米国国立医学図書館(NLM)

Treating Excessive Sweating: A Battle Against the Desert Heat

Facial hyperhidrosis, a condition characterized by excessive sweating, can be a real social and psychological burden. Imagine yourself living in a desert under a scorching sun, constantly feeling a stream of sweat running down your face! This study tackles this issue by comparing two treatments for facial hyperhidrosis: intradermal botulinum toxin A injections and topical 2% glycopyrrolate. Both methods are evaluated for their effectiveness, safety, and tolerability. The research team found that both treatments were effective, offering a welcome respite from the desert heat. However, botulinum toxin A injections provided longer relief, a welcome advantage when considering the potential for discomfort.

Cooling Down the Desert

The study revealed that 75% of patients in both treatment groups experienced a complete response, with botulinum toxin A lasting for up to 6 months compared to glycopyrrolate's shorter duration. The findings suggest that both treatments can effectively cool down the desert heat, but botulinum toxin A offers a longer-lasting solution. This is great news for patients seeking a more enduring solution for their hyperhidrosis.

Staying Cool in the Desert

The study suggests that both treatments are safe and tolerable, with minimal side effects. The researchers emphasize the need for patients to weigh the benefits and risks of each treatment and to consult with their healthcare provider to determine the best course of action. In essence, they are offering a roadmap for navigating the desert of facial hyperhidrosis, ensuring that patients can find a solution that best suits their individual needs and preferences.

Dr.Camel's Conclusion

Excessive sweating can feel like being trapped in a desert under a relentless sun. This research offers two cooling solutions: botulinum toxin A injections and topical glycopyrrolate. Both can provide welcome relief, but botulinum toxin A offers longer-lasting respite. It's a reminder that there are options available for managing hyperhidrosis, empowering patients to regain control over their discomfort and live more comfortably.

Date :
  1. Date Completed 2022-08-04
  2. Date Revised 2022-12-09
Further Info :

Pubmed ID

35917265

DOI: Digital Object Identifier

00042728-202208000-00009

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.